Clinical trials: Treatment of Induced Panic Attack
Treatment of Induced Panic Attack
Staccato Alprazolam in Panic Attack
We are developing Staccato™ Alprazolam for the treatment of Panic attacks associated with panic disorder. This study will provide an initial assessment of efficacy, and to continue to describe the tolerability and…
- Trial name
- NCT00477451
- Testing
- Inhaled alprazolam 1 mg, Inhaled alprazolam 2 mg, IV doxapram
- Where
- 3 sites in United States
- Volunteers
- 49 people
- Sponsor
- Alexza Pharmaceuticals, Inc.